Hansa Biopharma AB, a pioneer in enzyme technology for rare immunological conditions, announces that the Company has entered into an agreement with U.S.-based NovaQuest...
Hansa Biopharma, "Hansa", pioneer in enzyme technology for rare immunological conditions, announces the recommendation by the National Institute for Health and Care Excellence (NICE)...
